Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Eric Schmidt is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | TNGX | Buy Now | Tango Therapeutics | $8.82 | — | — | Reiterates | → Overweight | Get Alert |
| 06/18/2024 | INCY | Buy Now | Incyte | $60.57 | — | — | Reiterates | → Neutral | Get Alert |
| 06/17/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $42.42 | — | — | Reiterates | → Overweight | Get Alert |
| 05/30/2024 | ADCT | Buy Now | ADC Therapeutics | $3.15 | — | — | Initiates | → Overweight | Get Alert |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $54.64 | — | — | Reiterates | → Neutral | Get Alert |
| 04/23/2024 | INCY | Buy Now | Incyte | $60.57 | — | — | Initiates | → Neutral | Get Alert |
| 04/09/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $42.42 | — | — | Reiterates | → Overweight | Get Alert |
| 04/04/2024 | TNGX | Buy Now | Tango Therapeutics | $8.82 | — | — | Initiates | → Overweight | Get Alert |
| 03/14/2024 | RNA | Buy Now | Avidity Biosciences | $38.61 | 55.4% | → $60 | Initiates | → Overweight | Get Alert |
| 02/20/2024 | BIIB | Buy Now | Biogen | $228.88 | 35.88% | → $311 | Reiterates | Overweight → Overweight | Get Alert |
| 12/20/2023 | BIIB | Buy Now | Biogen | $228.88 | 35.88% | → $311 | Reiterates | Overweight → Overweight | Get Alert |
| 11/02/2023 | IMTX | Buy Now | Immatics | $12.05 | — | — | Initiates | → Overweight | Get Alert |
| 11/02/2023 | IMCR | Buy Now | Immunocore Hldgs | $38.01 | — | — | Initiates | → Overweight | Get Alert |
| 10/17/2023 | BLUE | Buy Now | bluebird bio | $1.00 | — | — | Initiates | → Neutral | Get Alert |
| 10/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.64 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/17/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $487.12 | -24.04% | → $370 | Reiterates | Overweight → Overweight | Get Alert |
| 10/17/2023 | EDIT | Buy Now | Editas Medicine | $4.84 | — | — | Downgrade | Overweight → Neutral | Get Alert |
